Analysis of the vaccine potential of a laboratory Escherichia coli strain in a Japanese flounder model

Escherichia coli DH5α is a genetically tailored laboratory strain that is commonly used for general cloning. In this study, the vaccine potential of DH5α was investigated. It was found that when used as a live vaccine, DH5α could afford effective protection upon Japanese flounder against Aeromonas h...

Full description

Saved in:
Bibliographic Details
Published inFish & shellfish immunology Vol. 28; no. 2; pp. 275 - 280
Main Authors Cheng, Shuang, Jiao, Xu-dong, Zhang, Min, Sun, Li
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.02.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Escherichia coli DH5α is a genetically tailored laboratory strain that is commonly used for general cloning. In this study, the vaccine potential of DH5α was investigated. It was found that when used as a live vaccine, DH5α could afford effective protection upon Japanese flounder against Aeromonas hydrophila infection. Vaccination with purified outer membrane proteins and lipopolysaccharides of DH5α failed to induce protective immunity against A. hydrophila. Specific antibody production was observed in fish immunized with DH5α, which lasted at least 8 weeks and was enhanced by a booster injection during the vaccination process. Analysis of the transcription profiles of immune-related genes showed that vaccination with DH5α heightened the expression of the genes encoding factors that are likely involved in both specific and nonspecific immunities. Furthermore, compared to the control fish, fish vaccinated with DH5α/pAQ1, which is DH5α harboring the plasmid pAQ1 that expresses the coding element of a Vibrio harveyi antigen, exhibited significantly improved survival rates following V. harveyi and A. hydrophila challenges. These results demonstrate that DH5α possesses intrinsic immunoprotective potential against A. hydrophila. This property, together with the feature of cloning friendliness, should render DH5α useful in the construction of cross-protective vaccines.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1050-4648
1095-9947
DOI:10.1016/j.fsi.2009.11.003